New research from the Jackson Laboratory for Genomic Medicine in Farmington, USA studied the genomic affects of radiation therapy on gliomas. Following an analysis from 190 paired primary and recurrent gliomas from the Glioma Longitudinal Analysis (GLASS) databases, it was determined that "an increased burden of radiation-induced deletions was significantly associated with poor patient outcome."
To read more about this study, which was recently presented at the MAP 2020 Virtual Congress, click here.
Study mentioned: 2MO – Kocakavuk E, Anderson KJ, Johnson KC, et al. Radiotherapy in cancer is associated with a deletion signature that contributes to poor patient outcomes. MAP 2020 Virtual Congress (9-10 October 2020).
No comments:
Post a Comment